

Expertise in the analysis & data trending aspects for Oral Solids Dosage forms, Injectable, Oral liquid dosages forms and Suspensions. Excellence in executing feasibility evaluation of analytical methods, method development & validations, writing of validation protocols, reports & other technical quality documents; skilled at conducting validation-related investigations and contributing to improvements in laboratory operations. Involved in various Query response analysis for various regulatory agencies. Supported to solve various plant level issues arrived during analysis of plant analysis for exhibit batches. Hands-on experience on chromatography technologies and data interpretation. Proven success in method development & validation activities in accordance with regulatory guidelines / industry best practice, in a range of analytical techniques. Strong capabilities in providing strategic leadership & technical expertise in analytical method development for release and stability testing of drug substances, Excipients, intermediates & drug product. Skilled in identifying analytical science capabilities & technology tools needed to enable method development, QC testing, and new drug candidate formulation development. Skilled in coordinating with other internal departments to review/approve qualification/validation of analytical methods. Successful in leading analytical method transfer, qualification & validation to commercial QC and as needed at manufacturing locations. Generated Method Development Report, Justifications reports and Test Methods for all the method developments performed. Following ALCOA+ during execution of LNB and maintaining the raw data for method developmental analysis. Leader with effective communication, interpersonal, problem-solving & troubleshooting skills, capabilities in experimental design and execution, capability to work on multiple projects simultaneously, as well as to work independently.
Got the above and beyond award for work in Sitagliptin and metformin HCl tablets project
Got the the spot award for Q1/Q2 study for FDA submission.